AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Xylometazoline Hydrochloride in South Africa
7 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SINE-OFF 12 HOUR SPRAY | L/16.1/174 | Pharmacare Limited û Woodmead | suspended | 30 Nov 2022 |
| OTRIVIN PAED | H/16.1/1381 | GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd | active | 1 Jan 1900 |
| OTRIVIN ADULT | H/16.1/1382 | GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd | active | 1 Jan 1900 |
| SINUTAB CHILDREN'S NASAL SPRAY | 46/16.1/0128 | Johnson & Johnson (Pty) Ltd û East London | active | 1 Jan 1900 |
| OTRIVIN MENTHOL | 31/16.1/0319 | GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd | active | 1 Jan 1900 |
| SINUTAB NASAL SPRAY | P/16.1/184 | Johnson & Johnson (Pty) Ltd û East London | active | 1 Jan 1900 |
| SINUTAB ADULT NASAL SPRAY | 46/16.1/0127 | Johnson & Johnson (Pty) Ltd û East London | active | 1 Jan 1900 |
Xylometazoline Hydrochloride — SAHPRA Registration Details
SAHPRA (South Africa) has 7 registered products containing Xylometazoline Hydrochloride, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Xylometazoline Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.